| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 02/11/2009 | CN100460421C Immunoglobulin variants and uses thereof |
| 02/11/2009 | CN100460417C Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase |
| 02/11/2009 | CN100460412C Process for preparing amine platinum complexes |
| 02/11/2009 | CN100460402C Therapeutic benzopyranone compounds used as intermediates. |
| 02/10/2009 | US7488963 Thin lightweight flexible cloth, tor treatment of garments with high molecular weight metal particles; for the manufacture of radiation attenuation garments; X-ray shielding garments |
| 02/10/2009 | US7488597 Polynucleotide encoding an intracellular estradiol binding protein |
| 02/10/2009 | US7488485 Viral proteins which stimulating immunology response |
| 02/10/2009 | CA2458067C Use of flibanserin in the treatment of sexual disorders |
| 02/10/2009 | CA2429574C Sterilisation of pharmaceuticals |
| 02/10/2009 | CA2355633C Skin care compositions containing cis-9, trans-11 linoleic acid |
| 02/05/2009 | WO2005000193A3 Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases |
| 02/05/2009 | WO2004075855A3 Process for in vivo treatment of specific biological targets in bodily fluid |
| 02/05/2009 | US20090036682 Crystalline form of 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline; used in the treatment of CNS and other disorders |
| 02/05/2009 | US20090036423 Immunosuppresant compounds and compositions |
| 02/05/2009 | US20090036381 Treatment of diabetes |
| 02/05/2009 | US20090036378 Use of Factor VIIa or a Tissue Factor Antagonist for Regulating Gene Expression and Cell Migration or Chemotaxis |
| 02/05/2009 | US20090035753 Novel druggable regions in the dengue virus envelope glycoprotein and methods of using the same |
| 02/05/2009 | US20090035375 Pharmaceutical compositions for acute glucocorticoid therapy |
| 02/05/2009 | US20090035263 Using granulocyte colony stimulating factor as therapeutic agent through a slow release mechanism, in treatment of spontaneous abortion, preeclampsia, preterm labor |
| 02/05/2009 | US20090035262 Compositions and methods for healthy pregnancy |
| 02/04/2009 | EP2020242A2 Improved Topical Medicaments and Methods for Photodynamic Treatment of Disease |
| 02/04/2009 | EP1648385A4 System and method for the photodynamic treatment of burns, wounds, and related skin disorders |
| 02/04/2009 | CN101357943A Glycoprotein compositions |
| 02/04/2009 | CN101357915A Diazabicyclic central nervous system active agents |
| 02/04/2009 | CN101357230A Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 02/04/2009 | CN100457757C Novel spiro compounds |
| 02/04/2009 | CN100457753C N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 02/04/2009 | CN100457738C Aryloxyphenyl and arylsulfanylphenyl piperazine derivatives |
| 02/04/2009 | CN100457731C Benzamide modulators of metabotropic glutamate receptors |
| 02/04/2009 | CN100457726C Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes |
| 02/04/2009 | CN100457705C Color stabilization of hydroquinone hydroxyethyl ether products |
| 02/04/2009 | CN100457115C Blood flow modifier and thrombus prophylactic agent or medicines |
| 02/04/2009 | CN100457108C Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 02/03/2009 | US7485707 Thermally stable crystalline epirubicin hydrochloride and method of making the same |
| 02/03/2009 | US7485706 Has a domain that preferentially binds to aggregations comprising at least two monomeric proteins linked to a second domain that recruits the aggregation modifying protein; neurotoxicity; neurodegenerative diseases |
| 02/03/2009 | US7485643 Bicyclic inhibitors of MEK and methods of use thereof |
| 02/03/2009 | US7485630 e.g. 2-{[(3'-Amino-1'-aza-2'-oxobicyclo[6.3.0]-undecyl)-11'-carbonyl]amino}-1,5-pentanedioic acid; tripeptide Gly-Pro-Glu (GPE) mimetic; enzymatic degradation, ischemic injury, hypoxic injury, reperfusion injury, and asphyxia |
| 02/03/2009 | US7485414 Identifying antagonist and/or agonist of neovascularization for treatment and prevention of cancer, reproductive, skin, visual and wound healing disorders |
| 02/03/2009 | US7485157 Quaternized azo or hydrazone hair dye mixed with cationic or amphoteric polymer; washfastness; weatherproof; radiation resistance; less selective and more uniform |
| 02/03/2009 | CA2538905C Withanamide glycoside and compositions and methods of use thereof |
| 02/03/2009 | CA2395881C Inhalation particles |
| 02/03/2009 | CA2341397C Immediate release tablet |
| 02/03/2009 | CA2223567C Modified meningococcal polysaccharide conjugate vaccines |
| 01/29/2009 | US20090029959 Antiglucocorticoid Therapy for the Prevention of Neurological Damage in Premature Infants |
| 01/29/2009 | US20090028829 Fusion proteins for the treatment of CNS |
| 01/29/2009 | US20090028819 comprising granulocyte colony stimulating factor peripheral blood stem cells (CD 34) for prevention of spontaneous abortion, preeclampsia, preterm labor or implantation failure during assisted reproduction |
| 01/28/2009 | CN100455583C 2-amino-9-(2-substituted ethyl)purines and preparing methods for 9- 4-acetoxy-3-(acetoxymethyl)but-1-yl]- 2- aminopurine using the same |
| 01/28/2009 | CN100455579C Compounds and compositions as protein kinase inhibitors |
| 01/28/2009 | CN100455289C Anticancer compositions comprising methenamine |
| 01/27/2009 | US7482455 Chemical compounds |
| 01/27/2009 | US7482428 Optimized expression of HPV 31 L1 in yeast |
| 01/27/2009 | US7482354 Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 01/27/2009 | US7482016 Immunogenic compositions comprising HIV-1 acetylated Tat polypeptides |
| 01/22/2009 | US20090023812 N,n-dihalogenated amino acids and derivatives |
| 01/22/2009 | US20090023760 anticarcinogenic agent; thymidylate synthase (TS) inhibitors; Tri-tert-butyl N-{N-{4-[N-((6RS)-2-methoxymethyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclopenta[g]quinazolin-6-yl)-N-(prop-2-ynyl)amino]benzoyl}-L- gamma -glutamyl}-D-glutamate |
| 01/22/2009 | US20090023718 Diamine and Iminodiacetic Acid Hydroxamic Acid Derivatives |
| 01/22/2009 | US20090023226 Variant Integrin Polypeptides and Uses Thereof |
| 01/22/2009 | US20090022725 antagonist antibody that blocks binding of IL-17; degenerative cartilaginous disorders and other inflammatory diseases |
| 01/21/2009 | EP1626964B1 New benzimidazole derivatives |
| 01/21/2009 | EP1626731B1 Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
| 01/21/2009 | EP1590004B1 Process for the production of improved thickened beverages for dysphagia |
| 01/21/2009 | EP1569680B1 Treatment of diabetes |
| 01/21/2009 | CN101347614A Growth hormone formulations |
| 01/21/2009 | CN101347431A Use of flibanserin in the treatment of sexual disorders |
| 01/20/2009 | US7479546 Pro104 antibody compositions and methods of use |
| 01/20/2009 | US7479507 Anti-inflammatory substituted phenols and elastomeric compositions for oral delivery of drugs |
| 01/20/2009 | CA2586146C Fluorocarbon aerosol medicaments |
| 01/20/2009 | CA2352483C Pharmaceutical aerosol composition containing hfa 227 and hfa 134a |
| 01/20/2009 | CA2338794C New oral formulation for 5-ht4 agonists or antagonists |
| 01/20/2009 | CA2325633C Steroidal sapogenins and their derivatives for treating alzheimer's disease |
| 01/15/2009 | US20090018193 Essential fatty acids in the prevention of cardiovascular events |
| 01/15/2009 | US20090018185 Compositions and products containing s-equol, and methods for their making |
| 01/15/2009 | US20090017077 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 01/15/2009 | US20090017065 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants |
| 01/14/2009 | EP2014298A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 01/14/2009 | EP2014285A1 NPYY5 antagonists |
| 01/14/2009 | EP2014180A1 Composition useful for the reduction of the cardivascular risk and foods that contain it |
| 01/14/2009 | EP1439870B1 Device for the delivery of a substance |
| 01/14/2009 | EP1300396B1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 01/14/2009 | CN101343302A Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives |
| 01/14/2009 | CN101343251A Thrombopoietin mimetics |
| 01/14/2009 | CN101343250A Thrombopoietin mimetics |
| 01/14/2009 | CN101342169A Thrombopoietin mimetics |
| 01/14/2009 | CN100451024C Metallocene compound, indene compound and application thereof |
| 01/14/2009 | CN100451016C Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors |
| 01/13/2009 | US7476743 Treating cellular proliferation disease with 1,2,5-triazol-5-one and as an anticancer agent and inhibitor of kinesins for treatment of hyperplasia or restenosis |
| 01/13/2009 | US7476692 useful for the treatment of cancer and other hyperproliferative disorders; a sphingolipid; lactic acid; and optionally a stabilizing agent; emulsion |
| 01/13/2009 | US7476688 Cyclic amidine derivatives |
| 01/13/2009 | US7476665 Benzodiazepine CGRP receptor antagonists |
| 01/13/2009 | US7476649 Antiproliferative and antiviral proteins and peptides |
| 01/13/2009 | US7476403 Controlled release dosage form for a sparingly water soluble to insoluble drug, and a mixture of a low viscosity polymer and a higher viscosity polymer such as hydroxypropyl cellulose; clarithromycin for example; less food effect on bioavailability; side effect reduction |
| 01/08/2009 | US20090013420 Psmcs as Modifiers of the Rb Pathway and Methods of Use |
| 01/08/2009 | US20090012175 Methods of treating cancer with HDAC inhibitors |
| 01/08/2009 | US20090011974 Scavenger Receptor B1 (Cla-1) Targeting for the Treatment of Infection, Sepsis and Inflammation |
| 01/08/2009 | US20090011031 Delivery of oral drugs |
| 01/08/2009 | US20090011006 Once daily formulations of tetracyclines |
| 01/08/2009 | US20090010938 Short immunomodulatory oligonucleotides |
| 01/08/2009 | US20090010931 restoring growth inhibition sensitivity to a tumor cell resistant to growth inhibition by HER2 antagonists; antibody produced by the hybridoma 4F10; PC-Cell Derived Growth Factor (PCDGF) |
| 01/08/2009 | US20090010856 Composition, Comprising Hydrofluoric Acid, for Inhibiting Dental Erosion |
| 01/07/2009 | EP2011510A2 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments |